• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Cancer, prior abdominal surgery linked to readmission after hysterectomy

byDenise PongandLeah Hawkins Bressler, MD, MPH
December 21, 2015
in Chronic Disease, Obstetrics, Oncology
Reading Time: 2 mins read
Pediatric cardiac surgery occurring at earlier age, with better outcomes over 50+ year review
Share on FacebookShare on Twitter

1. The overall 30-day admission rate following hysterectomy was 6%.

2. Women with malignancy and prior abdominal surgery were more likely to be readmitted.

Evidence Rating Level: 2 (Good)

Study Rundown: Hysterectomies are one of the most common surgeries in the United States, second only to cesarean deliveries. Indications for hysterectomy include benign diseases like leiomyomas (fibroids), abnormal uterine bleeding, pelvic organ prolapse and pain, as well as malignancy. Hysterectomy can be performed by vaginal, abdominal or laparoscopic surgery. While different surgical approaches and their associated operating times, duration of hospitalization and complication rates have been well studied, less is known about perioperative complications and rehospitalization following hysterectomy. Prior work has suggested that the rate of readmission for hysterectomy is between 3.4% and 12%. Given the current trend in using rehospitalization rates as an indicator of quality and value-based payment, interest has increased in assessing the frequency and clinical characteristics associated with postoperative hospitalizations.

In the present study, the authors assessed risk factors for readmission within 30 days after hysterectomy for both benign and malignant disease. They found that malignancy and prior abdominal surgery were associated with an increased likelihood of readmission after hysterectomy. Strengths of the study were inclusion and stratification of women with benign and malignant disease, as well as evaluation of numerous pre-, intra-, and post- operative risk factors. The study was limited by retrospective design and limited generalizability to medical centers with less experienced surgeons performing hysterectomy. Prospective studies are merited to assess reproducibility and evaluate the predictive value of findings.

Click to read the study in AJOG

RELATED REPORTS

2 Minute Medicine Rewind October 12, 2026

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

Most routine blood tests do not require prolonged fasting

Relevant Reading: Factors associated with 30-day hospital readmission after hysterectomy

In-Depth [retrospective cohort]: This study evaluated the incidence of and risk factors for readmission following hysterectomy among 1649 women treated at an academic medical center. The primary outcome of interest was unintended readmission within 30 days after hysterectomy. Preoperative, intraoperative and postoperative variables were also evaluated including patient age, clinical indication, previous abdominal surgeries, surgeon experience, operative duration, estimated blood loss, malignancy on pathology, and length of stay, among others.

The overall 30-day readmission rate was 6%. Among those with benign disease, prior abdominal surgery (OR 2.1, CI 1.1-4.3) was associated with readmission. Women with malignancy were more likely to be rehospitalized (p<0.0001) and in these women, blood loss >500mL (OR 3.3, CI 1.3-8.5), prolonged hospitalization >3 days (OR 16.6, CI 2.9-95.4) and worse physical status (OR 1.9, CI 1.1-3.5) were associated with readmission. Discharge on post-operative day 1 (OR 0.2, CI 0.03-0.8) and laparoscopic route of surgery (OR 0.3, CI 0.1-0.9) were associated with decreased odds of readmission.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Military traumatic brain injury associated with white matter abnormalities on MRI

Next Post

2 Minute Medicine Rewind December 21, 2015

RelatedReports

Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 12, 2026
Infectious Disease

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

October 9, 2026
2 Minute Medicine

Most routine blood tests do not require prolonged fasting

October 9, 2026
Artificial Intelligence

Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases

October 9, 2026
Next Post
Anti-TNF therapy for inflammatory bowel disease may induce skin lesions

2 Minute Medicine Rewind December 21, 2015

UTI associated with increased risk of preeclampsia

Early maternal exercise reduces the incidence of gestational hypertension

Computed tomography improves diagnostic certainty in the emergency department

Warning symptoms before cardiac arrest associated with improved survival

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind October 12, 2026
  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.